Evidence map›Paper›PMID 25524060›Full record

SynthesisPlacenta2015

A systematic review of placental pathology in maternal diabetes mellitus.

J Huynh, D Dawson, D Roberts, R Bentley-Lewis

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Placenta, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 5 pooled it
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 5 syntheses or guidelines pooled it, 243 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. High-mobility group box 1 at the time of parturition in women with gestational diabetes mellitus.American journal of reproductive immunology (New York, N.Y. : 1989) · 2019
    Trial
  7. Article
  8. Placental Pathophysiology and Developmental Programming of Adult Cardiometabolic Risk: A Narrative Review of Pregnancy Exposures.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Hofbauer Cells in Pregnancies Complicated by Gestational Diabetes Mellitus and Pathological Fetal Growth.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. First-trimester biomarkers of gestational diabetes mellitus: A scoping review.Acta obstetricia et gynecologica Scandinavica · 2025
    Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

J HuynhDepartment of Medicine/Diabetes Unit, Massachusetts General Hospital, Boston, MA, United States.
D DawsonDepartment of Medicine/Diabetes Unit, Massachusetts General Hospital, Boston, MA, United States.
D RobertsDepartment of Pathology, Massachusetts General Hospital, Boston, MA, United States.
R Bentley-LewisDepartment of Medicine/Diabetes Unit, Massachusetts General Hospital, Boston, MA, United States. Electronic address: rbentleylewis@mgh.harvard.edu.
Massachusetts General Hospital · US

Funding

Metabolomic profiling in the prediction of Gestational Diabetes MellitusR03DK096152 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BENTLEY-LEWIS, RHONDA · 2012 to 2014
$475k
NIDDK NIH HHS 1R03DK096152NIDDK NIH HHS R03 DK096152
6 · The paper itself

Abstract

introductionDuring a pregnancy complicated by diabetes, the human placenta undergoes a number of functional and structural pathologic changes, such as increased placental weight and increased incidence of placental lesions including villous maturational defects and fibrinoid necrosis. The pathologic findings reported have differed among studies, potentially reflecting differences in type of diabetes, study methodology, or glycemic control of study participants. Alternatively, these discrepancies may represent different biologic adaptations to distinct metabolic diseases.

methodsWe conducted a comprehensive review of English language citations in Pubmed and Embase using the keywords "diabetes", "placenta", AND "pathology". Abstracts were reviewed for relevance then full-text articles were reviewed in order to extract a comprehensive summary of current pathological findings associated with pregestational and gestational diabetes mellitus, as well as an understanding of the impact of glycemic control on placental pathology.

resultsPlacental abnormalities most consistently associated with maternal diabetes are an increased incidence of villous immaturity, increased measures of angiogenesis, and increased placental weight.

conclusionsThe literature suggests that, despite similarities in placental abnormalities, differences in placental pathology may reflect differences in pathophysiology among different types of diabetes. Consequently, standardization of terminology used to define placental lesions is warranted. Moreover, further research is needed to investigate the impact of pathophysiology, glycemic control and clinical factors, such as infant sex, weight and race, on placental structure and function.

Indexed as

Case-Control StudiesDiabetes, GestationalFemaleHumansPlacentaPlacenta DiseasesPregnancyPregnancy in DiabeticsDiabetes mellitusGestationalHistologyPathologyPlacentaType 1Type 2

Identifiers

PMID25524060
PMCPMC4339292
OpenAlexW2083360880

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.